| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.3B | $0.3B | $0.3B | $0.0B | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $1.52 | $1.44 | $1.59 | $1.67 | $1.57 | $0.37 | $0.37 | $0.31 |
| EPS (Diluted) | $1.52 | $1.44 | $1.59 | $1.67 | $1.56 | $0.37 | $0.37 | $0.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.6B | $15.2B | $16.0B | $16.5B | $15.9B | $14.4B | $11.3B | $11.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.2B | $0.3B | $0.2B | $1.7B | $2.0B | $0.2B | $0.2B |
| Total Liabilities | $13.3B | $13.0B | $13.9B | $14.5B | $13.8B | $12.4B | $9.3B | $9.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.3B | $2.2B | $2.1B | $1.9B | $2.1B | $2.0B | $2.0B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.2B | $0.9B | $0.5B | $-1.2B | $-1.7B | $-1.3B | $0.3B | $0.8B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $-1.2B | $-0.8B | $-0.6B | $1.3B | $2.9B | $-0.5B | $-1.0B |